The Use of Computer-Assisted Case-Based Reasoning to Support Clinical Decision-Making – A Scoping Review

Noll, Richard; Schaaf, Jannik; Storf, Holger

doi:10.1007/978-3-031-14923-8_26

Cited by 4 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In healthcare, clinical decision support systems (CDSS) have already been investigated for a variety of use cases [for a scoping review in the medical field see, e.g., Noll, Schaaf and Storf (113)], e.g., to determine the future direction of disease course and options for therapy (8,(114)(115)(116). One prominent example of such a CDSS in MS care is MSProDiscuss (117).…”

Section: Coming Together: Digital Pathways à La Carte For People With Msmentioning

confidence: 99%

Building digital patient pathways for the management and treatment of multiple sclerosis

Wenk,

Voigt,

Inojosa

et al. 2024

Front. Immunol.

View full text Add to dashboard Cite

Recent advances in the field of artificial intelligence (AI) could yield new insights into the potential causes of multiple sclerosis (MS) and factors influencing its course as the use of AI opens new possibilities regarding the interpretation and use of big data from not only a cross-sectional, but also a longitudinal perspective. For each patient with MS, there is a vast amount of multimodal data being accumulated over time. But for the application of AI and related technologies, these data need to be available in a machine-readable format and need to be collected in a standardized and structured manner. Through the use of mobile electronic devices and the internet it has also become possible to provide healthcare services from remote and collect information on a patient’s state of health outside of regular check-ups on site. Against this background, we argue that the concept of pathways in healthcare now could be applied to structure the collection of information across multiple devices and stakeholders in the virtual sphere, enabling us to exploit the full potential of AI technology by e.g., building digital twins. By going digital and using pathways, we can virtually link patients and their caregivers. Stakeholders then could rely on digital pathways for evidence-based guidance in the sequence of procedures and selection of therapy options based on advanced analytics supported by AI as well as for communication and education purposes. As far as we aware of, however, pathway modelling with respect to MS management and treatment has not been thoroughly investigated yet and still needs to be discussed. In this paper, we thus present our ideas for a modular-integrative framework for the development of digital patient pathways for MS treatment.

show abstract